SEPTEMBER 24, 2020 – Using alternating magnetic fields in technology created by UTSW researchers, Solenic Medical aims to provide a better way to treat prosthetic joint infections than the current standard of care. Recently, the startup received an FDA designation of a Breakthrough Device. >>Full Article

June 2, 2020 (Houston, Texas) – MassChallenge, a global network of zero-equity startup accelerators, today announced the 56 early-stage startups invited to join the 2020 MassChallenge Texas in Houston program. These startups have been rigorously vetted by a community of more than 500 expert judges and represent the top 11% of applications from around the world; the selected startups more than double the number of startups accepted to the program’s 2019 bootcamp. >>Full Article

April 16, 2020— The Texas A&M New Ventures Competition (TNVC) is hosting its annual competition completely online this year to protect competitors, judges and staff during the COVID-19 pandemic. Sixteen semifinalists and eight alternates for the 2020 competition will compete May 14 for hundreds of thousands in startup funds during online rounds of pitch competitions and judging. >>Full Article

HOUSTON, TX November 7, 2019—  Johnson & Johnson Innovation, JLABS  announced today at TMCx Demo Day 2019 that NERv Medical, PATH EX, and Solenic Medical have been selected as the award recipients in the JLABS @ TMC Breakthrough Medical Technologies QuickFire Challenge. The Challenge was designed to ignite innovation in health tech and provide the innovators with the best ideas resources to advance their science. The announcement was made by Allan Miranda, Head of JLABS Canada and Interim Head of JLABS @ TMC . >>Full Article

DALLASJune 19, 2019 — VIC Technology Venture Development, LLC (VIC) has announced that it has formed Solenic Medical, Inc. The company was established to develop and commercialize a method for treating prosthetic joint infection (PJI) based on technology exclusively licensed from University of Texas Southwestern Medical Center (UTSW). The patent-pending technology offers an approach for the eradication of biofilm from metallic implants. Advantages include non-invasive treatment of PJI through selective targeting of biofilms. >>Full Article

Comments are closed.